Delving into the Latest Updates on Shenzhen Haibin Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Infectious Diseases

Urogenital Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

PBPs(Bacterial penicillin-binding protein)	1

主要研究目的（SAD）：评价单次雾化吸入XYP-001后受试者的安全性和耐受性。次要研究目的（SAD）：评价单次雾化吸入XYP-001后受试者的XYP-001及其代谢产物的药代动力学特征。主要研究目的（MAD）：评价多次雾化吸入XYP-001后受试者的安全性和耐受性。次要研究目的（MAD）：评价多次雾化吸入XYP-001后受试者的XYP-001及其代谢产物的药代动力学特征及稳态情况；评价雾化吸入XYP-001后IPF受试者的XYP-001及其代谢产物的痰液药物峰浓度和谷浓度。

[Translation]

Primary study objective (SAD): To evaluate the safety and tolerability of subjects after a single nebulized inhalation of XYP-001. Secondary study objective (SAD): To evaluate the pharmacokinetic characteristics of XYP-001 and its metabolites in subjects after a single nebulized inhalation of XYP-001. Primary study objective (MAD): To evaluate the safety and tolerability of subjects after multiple nebulized inhalations of XYP-001. Secondary study objective (MAD): To evaluate the pharmacokinetic characteristics and steady-state of XYP-001 and its metabolites in subjects after multiple nebulized inhalations of XYP-001; To evaluate the sputum peak and trough drug concentrations of XYP-001 and its metabolites in IPF subjects after nebulized inhalation of XYP-001.

Start Date29 Nov 2022

Sponsor / Collaborator

Healthy Yuan Haibin Pharmaceutical Co., Ltd.

[+1]

CTR20221128 / CompletedPhase 3

沙美特罗替卡松吸入粉雾剂治疗成人哮喘有效性和安全性的多中心、随机、盲法、阳性平行对照临床研究

[Translation] A multicenter, randomized, blinded, positive parallel controlled clinical study on the efficacy and safety of salmeterol-fluticasone inhalation powder in the treatment of adult asthma

评价沙美特罗替卡松吸入粉雾剂治疗成人哮喘的有效性和安全性

[Translation]

To evaluate the efficacy and safety of salmeterol/fluticasone inhalation powder in the treatment of asthma in adults

Start Date10 Jun 2022

Sponsor / Collaborator

Healthy Yuan Haibin Pharmaceutical Co., Ltd.

[+1]

100 Clinical Results associated with Shenzhen Haibin Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shenzhen Haibin Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Shenzhen Haibin Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shenzhen Haibin Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Other

Login to view more data